title: Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment--a clinical report.
abstract: Treatment for significant hypoglycemia includes administration of dextrose containing agents, including 50% dextrose (D50%W) intravenously. Significant extravasation of D50%W can lead to complications, including skin and soft tissue injury, loss of limb, or death. The aim of this case report, using an interdisciplinary team approach, explores extravasation protocols as well as literature review, is to provide information about the proper use of hyaluronidase in patients with D50%W extravasations. A 46-year-old African American man presented to the emergency department (ED) after blood glucose level was initially 13 mg/dL. Emergency medical service established a large bore intravenous (IV) line in the right antecubital vein and administered a total of 50 g of D50%W. Upon arrival to the ED, the patient's level of consciousness had significantly improved. After arrival to the ED, the patient started complaining of pain in his right arm, near the site of the IV line insertion. On inspection, the IV site was grossly infiltrated. Hospital protocols for hyperosmolar infiltration were used. Extravasation is a common medical complication of infused medications and needs to be properly identified and treated. The multitude of skills from nursing, medicine, and pharmacy ensures that extravasation is managed appropriately and effectively to ensure safety to patients. Recognition, communication, and awareness of the institutional guidelines on how to treat infiltration and extravasation should be encouraged in all ED and intensive care unit medical personnel who deal with a variety of infusions and IV medications that have serious implications if not treated correctly.
authors.affiliation: University of Miami School of Nursing and Health Studies, Coral Gables, FL, USA. s.lawson1@miami.edu
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Lawson
authors.forename: William
authors.initials: W
authors.lastname: Brady
authors.forename: Ahmed
authors.initials: A
authors.lastname: Mahmoud
mesh_terms: D000931:Antidotes / Q000627:therapeutic use*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D005947:Glucose / Q000009:adverse effects* / Q000627:therapeutic use; D005950:Glucose Solution, Hypertonic / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D007003:Hypoglycemia / Q000188:drug therapy*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged
chemical_list: D000931:Antidotes; D005950:Glucose Solution, Hypertonic; D006821:Hyaluronoglucosaminidase; D005947:Glucose